A Safety, Efficacy and Tolerability Study in Pediatric Subjects With Asthma
Status:
Completed
Trial end date:
2013-06-01
Target enrollment:
Participant gender:
Summary
A Safety, Efficacy, and Tolerability Study of Daily Dosing with Levalbuterol Tartrate HFA MDI
and Placebo in Subjects Aged Birth to <48 Months with Asthma.